Uploaded March 2016 | Updated November 2026, 2 hours ago
John Essigmann SM ’72, PhD ’76
William R. (1956) and Betsy P. Leitch Professor of Chemistry, Toxicology, and Biological Engineering
Housemaster, Simmons Hall 2002–present
Housemaster, New House 1995–2002
John Essigmann is an award-winning teacher who draws on his interests in chemistry and toxicology in his cancer research. His novel interdisciplinary approach is based on a strategy called “lethal mutagenesis” or “viral decay acceleration,” an attempt to use a cancer cell’s own mutation process to eradicate the disease. One resulting drug, manufactured by Koronis Pharmaceuticals, which Professor Essigmann helped to found, is currently in clinical trials.
John Essigmann SM ’72, PhD ’76
William R. (1956) and Betsy P. Leitch Professor of Chemistry, Toxicology, and Biological Engineering
Housemaster, Simmons Hall 2002–present
Housemaster, New House 1995–2002
John Essigmann is an award-winning teacher who draws on his interests in chemistry and toxicology in his cancer research. His novel interdisciplinary approach is based on a strategy called “lethal mutagenesis” or “viral decay acceleration,” an attempt to use a cancer cell’s own mutation process to eradicate the disease. One resulting drug, manufactured by Koronis Pharmaceuticals, which Professor Essigmann helped to found, is currently in clinical trials.










